3 results
The primary objectives of the study are to characterize the safety and toxicity profiles of epcoritamab when co-administered with anti-neoplastic agents in subjects with B-cell NHL and to determine the recommended dose for further investigation of…
The primary objectives of the Phase Ib portion of the study are as follows:* To assess the safety and tolerability of the combination of polatuzumab vedotin with bendamustine and rituximab (BR) or bendamustine and obinutuzumab (BG) when administered…
The aim of this study is to assess the effects and side effects of the QWhet micro current wound stimulation device in up to 78 subjects with a chronic wound over a continuous period of 28 days.The collected (coded) data will be used by Q Care to…